Bouke de Jong

Medicine & Life Sciences

1. Agar 8%
2. Antigens 7%
3. bedaquiline 16%
4. Benin 7%
5. Buruli Ulcer 48%
6. Cetylpyridinium 8%
7. Clofazimine 7%
8. Democratic Republic of the Congo 12%
9. Drug Resistance 19%
10. Enzyme-Linked Immunospot Assay 11%
11. Ethiopia 10%
12. Extensively Drug-Resistant Tuberculosis 8%
13. Fluoroquinolones 15%
14. Gambia 21%
15. Genome 17%
16. Genomics 5%
17. Genotype 7%
18. Ghana 7%
19. Guinea 6%
20. High-Throughput Nucleotide Sequencing 8%
21. HIV 13%
22. Isoniazid 17%
23. Kanamycin 5%
24. Latent Tuberculosis 6%
25. Linezolid 6%
26. Lymph Node Tuberculosis 8%
27. Mali 7%
28. Multidrug-Resistant Tuberculosis 25%
29. Multiple Drug Resistance 6%
30. Mutation 20%
31. Mycobacterium 31%
32. Mycobacterium bovis 6%
33. Mycobacterium Infections 7%
34. Mycobacterium tuberculosis 100%
35. Mycobacterium ulcerans 21%
36. Niger 5%
37. Peru 6%
38. Pharmaceutical Preparations 24%
39. Polymerase Chain Reaction 6%
40. Population 9%
41. Pulmonary Tuberculosis 8%
42. Pyrazinamide 7%
43. Rifampin 42%
44. Sputum 24%
45. T-Lymphocytes 10%
46. Therapeutics 11%
47. Tuberculin Test 5%
48. Tuberculosis 99%
49. Tuberculosis Vaccines 5%
50. Western Africa 16%